In conclusion, despite these limitations, our meta-analysis advocates that methylated SOX17, CDO1, ZFP42, TAC1, FAM19A4, FHIT, MGMT, p16, and RASSF1A are useful biomarkers in the screening and auxiliary detection of lung cancer. Here, SOX17 is linked to lung cancer.